info icon

This is a non-core endpoint: only basic statistics are computed.

Malignant neoplasm of nasopharynx

C3_NASOPHARYNX

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 C11
  • Cause of death: ICD-9 147
  • Cause of death: ICD-8 147
  • Cancer registry: Topography ICD-O-3 C11
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

2 out of 7 registries used, show all original rules.

106

4. Check minimum number of events

None

106

5. Include endpoints

None

106

6. Filter based on genotype QC (FinnGen only)

98

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 98 40 58
Unadjusted period prevalence (%) 0.02 0.01 0.03
Median age at first event (years) 62.61 57.45 66.17

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
106
Matched controls
1060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
72.4
61
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
32.2
71.3
57
37
A03FA01
ATC
metoclopramide; systemic, rectal
25.7
67.2
68
69
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
813.3
52.2
47
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
+∞
47.5
42
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
47.5
42
*
C11.9
ICD-10 Finland
Malignant neoplasm: Nasopharynx, unspecified
+∞
39.0
35
*
8070/3-C11.9
ICD-O-3
Squamous cell carcinoma, NOS, of nasopharynx, NOS
+∞
39.0
35
*
N02AA05
ATC
oxycodone; systemic
12.1
37.2
53
81
WZC00
NOMESCO Finland
Treatment plan or consultation
10.6
34.2
67
148
H02AB02
ATC
dexamethasone; systemic
102.9
33.3
35
5
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
33.1
30
*
C11.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of nasopharynx
+∞
30.7
28
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
13.7
28.8
31
31
A04AA02
ATC
granisetron; systemic, transdermal
+∞
28.4
26
*
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
145.2
22.6
23
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
20.5
19
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
243.6
20.3
20
*
XX3DW
NOMESCO Finland
Time consuming IT work
20.4
20.0
30
20
A04AA01
ATC
ondansetron; systemic, rectal
27.3
19.9
27
13
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
86.2
19.5
21
*
C11.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of nasopharynx
+∞
19.4
18
*
EBA10
NOMESCO Finland
Operative extraction of tooth
8.1
18.8
30
49
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
45.6
18.5
22
6
R13
ICD-10 Finland
Dysphagia
9.0
18.3
26
37
C11.0
ICD-10 Finland
Malignant neoplasm: Superior wall of nasopharynx
+∞
18.2
17
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
214.4
18.1
18
*
H65.2
ICD-10 Finland
Chronic serous otitis media
60.9
17.7
20
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
22.9
17.5
25
14
SCA02
NOMESCO Finland
Preventive oral health care
8.1
17.2
27
43
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
17.1
16
*
C11.1
ICD-10 Finland
Malignant neoplasm: Posterior wall of nasopharynx
+∞
17.1
16
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
48.6
17.0
20
5
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
16.0
15
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
16.0
15
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
6.0
15.8
36
84
EP1AE
NOMESCO Finland
Neck ultrasound examination
18.1
14.3
22
15
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
86.2
14.0
15
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
13.8
13
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
28.5
12.9
17
7
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
12.8
12
*
L03AA13
ATC
pegfilgrastim; parenteral
146.6
12.7
13
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
26.5
12.0
16
7
ZX090
NOMESCO Finland
Other technic of radiotherapy
134.0
11.7
12
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
11.7
11
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
11.7
11
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
11.7
11
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
24.6
11.0
15
7
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
5.5
10.7
24
54
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
121.5
10.6
11
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
10.6
10
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
+∞
10.6
10
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
10.6
10
*
8010/3-C11.9
ICD-O-3
Carcinoma, NOS, of nasopharynx, NOS
+∞
10.6
10
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
10.6
10
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
19.1
10.2
15
9
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
44.6
10.2
12
*
H66.9
ICD-10 Finland
Otitis media, unspecified
14.2
9.7
16
13
A07AA02
ATC
nystatin; oral
8.5
9.6
21
30
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.6
9.6
57
261
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
9.5
9
*
9680/3-C11.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS
+∞
9.5
9
*
A04AD12
ATC
aprepitant; systemic
+∞
9.5
9
*
K11.70
ICD-10 Finland
Hypoptyalism
+∞
9.5
9
*
SAA03
NOMESCO Finland
Extended examination of mouth
3.5
9.3
53
235
UDM02
NOMESCO Finland
Sinoscopy
26.8
9.1
12
5
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
30.3
8.7
11
*
EBA15
NOMESCO Finland
Extraction of multiple teeth
14.4
8.7
14
11
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
14.4
8.7
14
11
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
5.1
8.6
20
46
H66.0
ICD-10 Finland
Acute suppurative otitis media
8.0
8.5
19
28
A01AB09
ATC
miconazole; local oral
5.3
8.5
19
42
8072/3-C11.9
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of nasopharynx, NOS
+∞
8.4
8
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
8.4
8
*
L03AA02
ATC
filgrastim; parenteral
+∞
8.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.4
8
*
ENA10
NOMESCO Finland
Biopsy of pharynx
+∞
8.4
8
*
JN4BD
NOMESCO Finland
Extensive body CT
8.1
8.2
18
26
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.5
7.7
21
55
R4190
NOMESCO Finland
Nutritional therapy
14.8
7.6
12
9
8070/3-C11.2
ICD-O-3
Squamous cell carcinoma, NOS, of lateral wall of nasopharynx
+∞
7.4
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.4
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.4
7
*
8070/3-C11.1
ICD-O-3
Squamous cell carcinoma, NOS, of posterior wall of nasopharynx
+∞
7.4
7
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
+∞
7.4
7
*
Z51.5
ICD-10 Finland
Palliative care
13.3
7.3
12
10
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
21.9
7.3
10
5
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
32.4
7.3
9
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
32.4
7.3
9
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
3.2
7.1
40
171
Z01.2
ICD-10 Finland
Dental examination
3.0
7.1
57
298
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
12.1
7.0
12
11
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
7.3
7.0
16
25
WX199
NOMESCO Finland
Other local analgesia
8.8
6.9
14
18
DFF00
NOMESCO Finland
Pure tone audiometry
3.9
6.7
22
66
A06AD11
ATC
lactulose; oral
3.6
6.7
26
88
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
6.6
36
150
SXB00
NOMESCO Finland
Removal of sutures from oral mucosa
6.1
6.5
17
32
DHA10
NOMESCO Finland
Biopsy of cavity of nose
12.1
6.5
11
10
J01CE02
ATC
phenoxymethylpenicillin; oral
3.3
6.4
83
551
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
11.0
6.2
11
11
WX002
NOMESCO Finland
Sedation and analgesia
3.2
6.0
29
112

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
38
23
25.20
47.67
1.5
1.3
—
—
—
0
0
33
79
5.61
13.92
2.2
1.9
—
—
—
0
0
58
239
4.15
12.00
3.0
1.4
—
—
—
0
0
68
337
3.84
10.28
7.0
5.2
0.72
0.71
%
0.07
62
310
65
313
3.78
10.27
5.9
3.3
34.53
35.95
g/l
0.96
58
294
78
432
4.05
9.79
17.0
6.2
3.89
4.11
e9/l
0.41
66
375
68
351
3.61
9.37
7.0
5.2
2.97
3.09
%
0.15
62
323
68
352
3.60
9.31
7.3
5.6
9.16
8.64
%
0.69
62
325
68
356
3.54
9.06
7.3
5.4
26.23
27.63
%
0.36
63
330
67
354
3.43
8.67
7.0
5.1
58.28
56.70
%
0.41
62
329
60
309
3.17
7.88
8.0
5.4
1.22
1.21
mmol/l
1.00
55
275
68
381
3.19
7.63
6.6
5.0
0.56
0.56
e9/l
0.10
55
333
68
381
3.19
7.63
6.8
5.0
0.04
0.04
e9/l
0.96
55
337
68
384
3.15
7.47
6.8
5.1
1.50
1.78
e9/l
1.83
59
346
65
361
3.07
7.30
9.6
5.7
1.22
1.21
mmol/l
0.49
56
317
64
355
3.03
7.16
7.9
5.5
—
—
—
0
0
68
394
3.02
6.96
7.0
5.1
0.16
0.20
e9/l
2.00
57
347
42
191
2.99
6.64
4.0
3.7
—
—
—
0
0
49
245
2.86
6.49
5.3
2.1
2.36
2.35
mmol/l
0.08
43
210
16
42
4.31
5.78
1.3
1.5
—
—
—
0
0
42
206
2.72
5.62
2.4
1.9
—
—
—
0
0
24
87
3.27
5.49
1.4
1.7
—
—
—
0
0
63
384
2.58
5.33
12.2
12.3
1.24
1.28
inr
0.12
14
116
20
67
3.45
5.15
1.2
1.7
—
—
—
0
0
21
74
3.29
5.00
1.5
1.3
—
—
—
0
0
16
49
3.67
4.69
1.8
1.1
—
—
—
0
0
27
118
2.73
4.41
1.8
1.8
—
—
—
0
0
32
163
2.38
3.77
12.8
4.3
—
—
—
0
0
21
91
2.63
3.44
1.8
1.5
—
—
—
0
0
37
209
2.18
3.38
5.4
3.1
7.39
7.40
ph
—
7
34
32
178
2.14
3.00
1.5
1.3
—
—
—
0
0
17
71
2.66
2.98
3.4
3.1
—
—
—
0
0
6
10
6.28
2.73
1.3
1.1
—
—
—
0
0
7
15
4.91
2.64
1.9
2.0
—
—
—
0
0
17
76
2.47
2.60
2.0
1.6
390.24
367.00
nmol/l
0.20
17
68
5
7
7.42
2.57
1.2
1.3
—
—
—
0
0
36
227
1.89
2.33
3.5
2.3
335.17
11252.23
umol/l
1.79
30
195
7
18
4.09
2.29
1.3
1.1
—
—
—
0
0
5
10
5.18
2.09
1.4
1.5
—
—
—
0
0
12
51
2.53
2.03
1.4
1.3
—
—
—
0
0
21
115
2.03
2.01
2.8
2.8
3.24
1.48
e6/l
0.58
11
61
76
872
0.55
1.94
5.4
5.3
2.89
2.71
mmol/l
0.69
67
809
69
808
0.58
1.80
5.5
6.2
39.50
40.01
mmol/mol
0.24
60
761
71
823
0.58
1.73
4.3
4.3
1.35
1.33
mmol/l
0.10
63
758
74
847
0.58
1.68
5.0
4.7
1.40
1.45
mmol/l
0.44
67
786
46
339
1.63
1.64
10.9
7.8
0.00
0.00
e9/l
-0.00
32
281
75
852
0.59
1.57
4.9
4.7
4.78
4.61
mmol/l
0.56
68
795
21
323
0.56
1.54
2.9
3.1
—
—
—
0
0
7
29
2.51
1.42
2.7
1.8
—
—
—
0
0
6
26
2.38
1.20
4.2
1.7
—
—
—
0
0
0
33
0.00
1.18
0.0
3.2
—
—
—
0
0
0
35
0.00
1.17
0.0
7.2
—
—
—
0
0
7
32
2.27
1.10
28.7
10.2
—
—
—
0
0
10
53
1.98
1.05
6.0
3.0
1.22
1.21
mmol/l
—
10
45
71
615
1.47
1.04
5.5
3.7
14.83
14.79
pmol/l
0.04
66
553
29
211
1.52
1.03
3.4
2.7
—
—
—
0
0
0
29
0.00
0.99
0.0
2.9
—
3.94
—
0
29
62
529
1.41
0.95
4.7
3.8
—
—
—
0
0
17
112
1.62
0.92
1.2
1.2
—
—
—
0
0
26
193
1.46
0.84
3.4
2.6
—
—
—
0
0
25
185
1.46
0.82
4.0
3.7
528.40
350.52
ng/l
0.13
20
146
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
29
223
1.41
0.78
3.9
2.8
29.67
328.40
e6/l
0.53
23
173
5
23
2.23
0.77
8.0
4.2
—
—
—
0
0
77
835
0.72
0.74
4.6
4.8
6.03
6.06
mmol/l
0.04
69
763
5
26
1.97
0.71
1.4
1.4
—
—
—
0
0
42
350
1.33
0.69
1.6
1.9
90.02
94.45
pmol/l
0.26
16
178
26
202
1.38
0.66
3.8
2.7
0.24
0.30
e6/l
0.19
20
156
82
758
1.36
0.61
6.0
4.5
1.99
1.93
mu/l
0.13
77
690
22
277
0.74
0.56
3.0
3.1
7.32
7.72
mmol/l
0.16
15
236
11
74
1.54
0.56
2.1
3.6
2.65
1.65
mmol/l
0.81
11
62
22
270
0.77
0.47
2.5
3.2
8.06
297.98
mg/l
0.69
14
178
31
263
1.25
0.42
5.7
3.1
39.21
72.02
e6/l
0.35
24
188
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
5
34
1.49
0.41
2.2
1.5
—
—
—
0
0
11
80
1.42
0.40
1.1
1.2
—
—
—
0
0
29
248
1.23
0.37
6.2
3.9
—
—
—
0
0
6
41
1.49
0.37
20.8
9.1
26.82
24.90
mmol/l
—
6
41
23
192
1.25
0.36
2.1
1.7
0.85
1.15
mg/l
0.53
16
155
19
155
1.28
0.35
2.6
1.3
2.51
2.68
g/l
0.15
14
87
11
143
0.74
0.34
1.2
1.3
10.28
28.19
iu/ml
—
6
47
6
87
0.67
0.34
1.7
1.4
—
—
—
0
0
6
45
1.35
0.34
4.3
3.6
—
—
—
0
0
10
74
1.39
0.33
2.1
3.7
5.68
5.88
kpa
—
10
69
72
679
1.19
0.31
28.2
13.9
14.60
14.66
%
0.03
67
665
89
856
1.25
0.30
20.8
11.3
—
—
—
0
0
36
396
0.86
0.25
4.1
3.3
0.00
0.00
estimate
—
6
65
25
283
0.85
0.25
3.5
3.8
1.01
9.30
mg/mmol
2.58
15
179
5
39
1.30
0.23
1.4
1.2
—
—
—
0
0
5
42
1.20
0.22
2.6
2.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
91
886
1.19
0.19
27.7
13.8
79.53
81.82
umol/l
0.36
91
886
36
389
0.89
0.19
5.7
4.5
0.00
0.00
estimate
—
6
65
37
399
0.89
0.19
4.9
3.9
2.30
1.95
ug/l
0.36
31
356
7
60
1.18
0.18
1.6
2.8
—
—
—
0
0
7
61
1.16
0.18
20.7
9.6
—
—
—
0
0
58
604
0.91
0.14
4.0
3.9
—
—
—
0
0
33
353
0.91
0.14
3.9
3.5
34.66
53.79
ng/l
0.49
28
242
11
94
1.19
0.13
2.5
2.4
2.21
2.32
g/l
0.26
11
86
19
210
0.88
0.13
4.4
3.0
—
—
—
0
0
5
47
1.07
0.09
2.8
2.2
—
—
—
0
0
18
195
0.91
0.09
4.9
3.6
0.00
0.00
estimate
—
6
62
5
62
0.80
0.08
14.6
3.1
—
—
—
0
0
6
74
0.80
0.08
1.3
1.5
—
—
—
0
0
37
384
0.94
0.06
4.2
3.3
0.00
0.00
estimate
—
7
72
10
90
1.12
0.05
2.5
2.4
20.43
25.34
%
—
10
78
10
94
1.07
0.01
15.4
6.7
102.40
104.81
mmol/l
—
10
94
92
922
0.98
0.00
34.3
17.3
39.04
40.79
%
2.74
85
861
17
172
0.99
0.00
1.6
1.7
1149.71
1315.46
nmol/l
0.33
11
137
22
221
0.99
0.00
2.4
2.5
0.64
0.71
ug/l
0.28
15
134
18
181
0.99
0.00
2.9
3.2
—
—
—
0
0
11
111
0.99
0.00
2.6
2.3
11.66
14.47
umol/l
0.70
11
97
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
1.51
—
0
8
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
164.55
—
0
8
0
9
0.00
-0.00
0.0
1.3
—
34.56
—
0
9
0
6
0.00
-0.00
0.0
1.2
—
1.28
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
91.63
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
1.3
1.3
—
32.00
—
0
5
6
61
0.98
-0.00
2.0
2.7
6.33
4.27
kpa
—
6
55
0
5
0.00
-0.00
0.0
1.0
—
2.76
—
0
5
5
54
0.92
-0.00
1.8
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
284.70
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
12.20
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
285.20
—
0
5
0
6
0.00
-0.00
0.0
3.0
—
37883.33
—
0
6
0
5
0.00
-0.00
0.0
10.8
—
0.58
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
1.59
—
0
6

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: C3_NASOPHARYNX – Malignant neoplasm of nasopharynx

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).